DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9fcftw/discovery_stage) has announced the addition of the "Discovery Stage Partnering Terms and Agreements" report to their offering.
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
This report contains over 2,500 links to online copies of actual discovery stage deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
Some of the Companies Mentioned include:
- Abbott Japan
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Cypress Bioscience
- Cytokinetics
- Daiichi Sankyo
- Eli Lilly
- Enanta Pharmaceuticals
- Forest Laboratories
- Genzyme
- Gilead Sciences
- GlaxoSmithKline
- GTx
- Hyperion Therapeutics
- Ironwood Pharmaceuticals
- Janssen Research & Development
- KaloBios Pharmaceuticals
- La Jolla Pharmaceutical
- Merck and Co
- Novartis Consumer Health
- Orexigen Therapeutics
- Pfizer
- Roche
- Sanofi-Aventis
- Schering-Plough
- Solvay
- Teva Pharmaceuticals
- Ucyclyd Pharma
- Victory Pharma
- Wyeth
- Xenoport
- ZymoGenetics
For more information visit http://www.researchandmarkets.com/research/9fcftw/discovery_stage
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
